INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Diabetes mellitus is one of the most common chronic diseases in the country and worldwide, which involves inappropriately increased blood sugar level. Due to its rising prevalence, India faces several challenges in diabetes management. Obesity is another leading risk factor for Type 2 diabetes mellitus (T2DM). There is a strong relation between obesity and diabetes. Having excess body fat is a risk factor for diabetes, and it can also affect a person’s health. To help, manage and potentially prevent diabetes some advanced treatments are needed. Glucagon like peptide 1 (GLP-1) and Glucose-dependent insulinotropic polypeptide (GIP) based therapy is the newly established treatment which can helps to minimise glycemic levels, enhance insulin sensitivity and reduce body weight. Tirzepatide, a dual GLP-1/GIP receptor agonist, known as ‘twincretin’, a synthetic peptide analogue of 39 amino acids engineered from the native GIP sequence and contains C20 fatty diacid moiety. Incretin hormones including mainly GLP/GIP-1 are peptides released in the intestine in response to the presence of nutrients in its lumen. They stimulates insulin secretion, inhibits glucagon secretion at pancreatic α cells and also have an effect on extrapancreatic influences as slowing of gastric emptying which increases the feeling of fullness. Tirzepatide could eventually be developed in the future seem to be a promising furthest advance for the management of several cardiometabolic settings. In the present review article, we have made an attempt to explore the characteristics of Tirzepatide including it’s pharmacokinetic and pharmacodynamic activity, structure, synthesis, clinical development in the management of T2DM.
"THE EMERGING ROLE OF TIRZEPATIDE, DUAL GLP-1 AND GIP RECEPTOR AGONIST IN THE MANAGEMENT OF T2DM AND OBESITY: A REVIEW.", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 11, page no.b18-b30, November-2022, Available :http://www.ijnrd.org/papers/IJNRD2211104.pdf
Downloads:
000118744
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn